Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christi L McElheny

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Microbiology Spectrum|November 10, 2021
<i>In Vitro</i> Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirAChristi L McElheny, Erin L Fowler, Alina Iovleva, et al.
Journal of Clinical Microbiology|January 1, 2016
Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor CombinationsGina K Thomson, James W Snyder, Christi L McElheny, et al.
Antimicrobial Agents and Chemotherapy|June 9, 2016
In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical StrainsSarah L Bowler, Caressa N Spychala, Christi L McElheny, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Contribution of the TetB Efflux Pump to Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii StrainsPeng Wang, Christi L McElheny, Roberta T Mettus, et al.
Microbiology Spectrum|December 23, 2021
Performance of Conventional Urine Culture Compared to 16S rRNA Gene Amplicon Sequencing in Children with Suspected Urinary Tract InfectionChristopher W Marshall, Marcia Kurs-Lasky, Christi L McElheny, et al.
Msphere|August 15, 2023
Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic <i>Escherichia coli</i> among children in the United StatesRauf Salamzade, Christi L McElheny, Abigail L Manson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to CefepimeRyan K Shields, Alina Iovleva, Ellen G Kline, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2017
Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative PathogensRyota Ito, Adam D Tomich, Christi L McElheny, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2025
<i>In vitro</i> evolution of durlobactam resistance in NDM-producing <i>Escherichia coli</i> due to a single mutation in <i>mrdA</i> encoding penicillin-binding protein 2Christi L McElheny, Erika L Butcher, Akito Kawai, et al.
Emerging Infectious Diseases|October 22, 2015
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USAHind Alrowais, Christi L McElheny, Caressa N Spychala, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Microbiology Spectrum|November 10, 2021
<i>In Vitro</i> Evolution of Cefiderocol Resistance in an NDM-Producing Klebsiella pneumoniae Due to Functional Loss of CirAChristi L McElheny, Erin L Fowler, Alina Iovleva, et al.
Journal of Clinical Microbiology|January 1, 2016
Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor CombinationsGina K Thomson, James W Snyder, Christi L McElheny, et al.
Antimicrobial Agents and Chemotherapy|June 9, 2016
In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical StrainsSarah L Bowler, Caressa N Spychala, Christi L McElheny, et al.
Antimicrobial Agents and Chemotherapy|July 26, 2017
Contribution of the TetB Efflux Pump to Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii StrainsPeng Wang, Christi L McElheny, Roberta T Mettus, et al.
Microbiology Spectrum|December 23, 2021
Performance of Conventional Urine Culture Compared to 16S rRNA Gene Amplicon Sequencing in Children with Suspected Urinary Tract InfectionChristopher W Marshall, Marcia Kurs-Lasky, Christi L McElheny, et al.
Msphere|August 15, 2023
Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic <i>Escherichia coli</i> among children in the United StatesRauf Salamzade, Christi L McElheny, Abigail L Manson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2020
Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to CefepimeRyan K Shields, Alina Iovleva, Ellen G Kline, et al.
Antimicrobial Agents and Chemotherapy|October 11, 2017
Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative PathogensRyota Ito, Adam D Tomich, Christi L McElheny, et al.
Antimicrobial Agents and Chemotherapy|October 10, 2025
<i>In vitro</i> evolution of durlobactam resistance in NDM-producing <i>Escherichia coli</i> due to a single mutation in <i>mrdA</i> encoding penicillin-binding protein 2Christi L McElheny, Erika L Butcher, Akito Kawai, et al.
Emerging Infectious Diseases|October 22, 2015
Fosfomycin Resistance in Escherichia coli, Pennsylvania, USAHind Alrowais, Christi L McElheny, Caressa N Spychala, et al.
Pageof 5